Amyotrophic lateral sclerosis.
暂无分享,去创建一个
[1] E. Goodall,et al. Genetics of Familial Amyotrophic Lateral Sclerosis , 2012 .
[2] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[3] J. Julien,et al. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. , 2011, Brain : a journal of neurology.
[4] J. Haines,et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.
[5] V. Gribkoff,et al. Safety, Tolerability, and Pharmacokinetics of KNS‐760704 (Dexpramipexole) in Healthy Adult Subjects , 2011, Journal of clinical pharmacology.
[6] Christopher Kennard,et al. Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. , 2011, Archives of neurology.
[7] C. Haass,et al. TDP-43 and FUS: a nuclear affair , 2011, Trends in Neurosciences.
[8] A. Kuhlmey,et al. Delay in diagnosis of muscle disorders depends on the subspecialty of the initially consulted physician , 2011, BMC health services research.
[9] E. Huey,et al. FTD and ALS: a tale of two diseases. , 2011, Current Alzheimer research.
[10] C. Heckman,et al. Stronger is not always better: Could a bodybuilding dietary supplement lead to ALS? , 2011, Experimental Neurology.
[11] R. Reiter,et al. Levels of membrane fluidity in the spinal cord and the brain in an animal model of amyotrophic lateral sclerosis , 2011, Journal of bioenergetics and biomembranes.
[12] A. Chiò,et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[13] S. Messina,et al. The diagnosis of Amyotrophic lateral sclerosis in 2010. , 2011, Archives italiennes de biologie.
[14] R. Takahashi,et al. Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease , 2011, Acta Neuropathologica.
[15] M. Thun,et al. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. , 2011, Archives of neurology.
[16] R. Baloh,et al. Implications of the prion-related Q/N domains in TDP-43 and FUS , 2011, Prion.
[17] K. Wada,et al. TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase , 2010, Neurochemistry International.
[18] Pamela A McCombe,et al. Effects of gender in amyotrophic lateral sclerosis. , 2010, Gender medicine.
[19] K. Talbot. Do twin studies still have anything to teach us about the genetics of amyotrophic lateral sclerosis? , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[20] O. Hardiman,et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[21] G. Bernardi,et al. Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture , 2010, Experimental Neurology.
[22] Robert H. Brown,et al. Screening for inhibitors of the SOD1 gene promoter: Pyrimethamine does not reduce SOD1 levels in cell and animal models , 2010, Neuroscience Letters.
[23] I. Mackenzie,et al. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia , 2010, The Lancet Neurology.
[24] J. Tainer,et al. Characterization of a Y-Family DNA Polymerase eta from the Eukaryotic Thermophile Alvinella pompejana , 2010, Journal of nucleic acids.
[25] J. Lachey,et al. Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type. , 2010, Journal of applied physiology.
[26] V. Olkkonen,et al. ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. , 2010, Journal of neurochemistry.
[27] I. Mackenzie,et al. ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import , 2010, The EMBO journal.
[28] R. Tibbetts,et al. Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA* , 2010, The Journal of Biological Chemistry.
[29] Huilin Zhou,et al. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS , 2010, Proceedings of the National Academy of Sciences.
[30] S. Sathasivam. Motor neurone disease: clinical features, diagnosis, diagnostic pitfalls and prognostic markers. , 2010, Singapore medical journal.
[31] S. Schmidt,et al. Association of ALS with head injury, cigarette smoking and APOE genotypes , 2010, Journal of the Neurological Sciences.
[32] D. Cleveland,et al. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.
[33] J. Tainer,et al. The structural biochemistry of the superoxide dismutases. , 2010, Biochimica et biophysica acta.
[34] M. Strong. The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS) , 2010, Journal of the Neurological Sciences.
[35] M. Hernán,et al. Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study , 2010, BMC neurology.
[36] C. Armon. Smoking may be considered an established risk factor for sporadic ALS , 2009, Neurology.
[37] P. Lamberti,et al. Current and emerging treatments for amyotrophic lateral sclerosis , 2009, Neuropsychiatric disease and treatment.
[38] Hyoung-Gon Lee,et al. All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease , 2009, Expert review of neurotherapeutics.
[39] M. Hernán,et al. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population‐based study , 2009, European journal of neurology.
[40] S. Sasaki,et al. Lifestyle factors and risk of amyotrophic lateral sclerosis: a case-control study in Japan. , 2009, Annals of epidemiology.
[41] Michel Dib,et al. Biomarkers in Amyotrophic Lateral Sclerosis , 2009, Molecular Diagnosis & Therapy.
[42] D. Cleveland,et al. Rethinking ALS: The FUS about TDP-43 , 2009, Cell.
[43] Myoung-Eun Han,et al. Reduction of ischemia-induced cerebral injury by all-trans-retinoic acid , 2009, Experimental Brain Research.
[44] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[45] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[46] John A Tainer,et al. Superoxide dismutase from the eukaryotic thermophile Alvinella pompejana: structures, stability, mechanism, and insights into amyotrophic lateral sclerosis. , 2009, Journal of molecular biology.
[47] J. Yates,et al. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS , 2009, Proceedings of the National Academy of Sciences.
[48] M. Miranda,et al. Spatial analysis of the etiology of amyotrophic lateral sclerosis among 1991 Gulf War veterans. , 2008, Neurotoxicology.
[49] B. Kalmar,et al. Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS , 2008, Journal of neurochemistry.
[50] V. Gribkoff,et al. KNS‐760704 [(6R)‐4,5,6,7‐tetrahydro‐N6‐propyl‐2, 6‐benzothiazole‐diamine dihydrochloride monohydrate] for the Treatment of Amyotrophic Lateral Sclerosis , 2008, CNS neuroscience & therapeutics.
[51] Hynek Wichterle,et al. Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.
[52] A. Riecker,et al. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis , 2008, Nature Clinical Practice Neurology.
[53] S. Grambow,et al. Amyotrophic Lateral Sclerosis among 1991 Gulf War Veterans: Evidence for a Time-Limited Outbreak , 2008, Neuroepidemiology.
[54] Takanori Yokota,et al. Als-linked Mutant Sod1 Induces Er Stress-and Ask1-dependent Motor Neuron Death by Targeting Derlin-1 -induced Cell Death Remains Controversial. Here We Show That Sod1 Mut Specifically Interacted with Derlin-1, a Component of Endoplasmic Reticulum (er)-associated Degradation (erad) Machinery and Trig , 2022 .
[55] C. Lomen‐Hoerth,et al. Amyotrophic Lateral Sclerosis from Bench to Bedside , 2008, Seminars in neurology.
[56] Tom Misteli,et al. TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression , 2008, Proceedings of the National Academy of Sciences.
[57] M. Swash,et al. Electrodiagnostic criteria for diagnosis of ALS , 2008, Clinical Neurophysiology.
[58] H. Paulson,et al. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. , 2008, The Journal of clinical investigation.
[59] J. E. Kranz,et al. Design, power, and interpretation of studies in the standard murine model of ALS , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[60] P. Reddi,et al. A Novel CpG-free Vertebrate Insulator Silences the Testis-specific SP-10 Gene in Somatic Tissues , 2007, Journal of Biological Chemistry.
[61] J. Trojanowski,et al. TDP-43 Proteinopathies: Neurodegenerative Protein Misfolding Diseases without Amyloidosis , 2007, Neurosignals.
[62] A. Al-Chalabi,et al. Amyotrophic Lateral Sclerosis in South-East England: A Population-Based Study , 2007, Neuroepidemiology.
[63] J. Alappat. ETHNIC VARIATION IN THE INCIDENCE OF ALS: A SYSTEMATIC REVIEW , 2007, Neurology.
[64] Asako Otomo,et al. Molecular and cellular function of ALS2/alsin: Implication of membrane dynamics in neuronal development and degeneration , 2007, Neurochemistry International.
[65] P. Wicks. Excessive yawning is common in the bulbar‐onset form of ALS , 2007, Acta psychiatrica Scandinavica.
[66] L. Hayward,et al. Interaction between Familial Amyotrophic Lateral Sclerosis (ALS)-linked SOD1 Mutants and the Dynein Complex* , 2007, Journal of Biological Chemistry.
[67] E. Abel. Football Increases the Risk for Lou Gehrig's Disease, Amyotrophic Lateral Sclerosis , 2007, Perceptual and motor skills.
[68] M. Strong,et al. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein , 2007, Molecular and Cellular Neuroscience.
[69] B. Traynor,et al. Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis , 2007, Expert opinion on emerging drugs.
[70] M. Benatar. Lost in translation: Treatment trials in the SOD1 mouse and in human ALS , 2007, Neurobiology of Disease.
[71] P. Garagnani,et al. Simple method for haplotyping the poly(TG) repeat in individuals carrying the IVS8 5T allele in the CFTR gene. , 2007, Clinical chemistry.
[72] R. Henry,et al. Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. , 2007, Archives of neurology.
[73] H. Akiyama,et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.
[74] J. Zhu,et al. Amyotrophic Lateral Sclerosis 2-Deficiency Leads to Neuronal Degeneration in Amyotrophic Lateral Sclerosis through Altered AMPA Receptor Trafficking , 2006, The Journal of Neuroscience.
[75] V. Koliatsos,et al. Human Neural Stem Cell Grafts Ameliorate Motor Neuron Disease in SOD-1 Transgenic Rats , 2006, Transplantation.
[76] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[77] D. Cleveland,et al. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.
[78] Robert H. Brown,et al. Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.
[79] B. Monia,et al. Antisense oligonucleotide therapy for neurodegenerative disease. , 2006, The Journal of clinical investigation.
[80] G. Hicks,et al. TLS, EWS and TAF15: a model for transcriptional integration of gene expression. , 2006, Briefings in functional genomics & proteomics.
[81] R. Olney,et al. The effects of executive and behavioral dysfunction on the course of ALS , 2005, Neurology.
[82] P. Andersen,et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives , 2005, European journal of neurology.
[83] S. Reske,et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD , 2005, Annals of neurology.
[84] B. Schürmann,et al. The Oral Antidiabetic Pioglitazone Protects from Neurodegeneration and Amyotrophic Lateral Sclerosis-Like Symptoms in Superoxide Dismutase-G93A Transgenic Mice , 2005, The Journal of Neuroscience.
[85] P. Ince,et al. Return of the cycad hypothesis – does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? , 2005, Neuropathology and applied neurobiology.
[86] L. Greensmith,et al. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice , 2005, The Journal of cell biology.
[87] M. Wicklund. Amyotrophic lateral sclerosis: possible role of environmental influences. , 2005, Neurologic clinics.
[88] G. Hicks,et al. The RNA Binding Protein TLS Is Translocated to Dendritic Spines by mGluR5 Activation and Regulates Spine Morphology , 2005, Current Biology.
[89] S. Cary,et al. The splicing factor U2AF65 is functionally conserved in the thermotolerant deep-sea worm Alvinella pompejana. , 2005, Biochimica et biophysica acta.
[90] A. Chiò,et al. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. , 2005, Brain : a journal of neurology.
[91] P. Sarradin,et al. Thermal selection of PGM allozymes in newly founded populations of the thermotolerant vent polychaete Alvinella pompejana , 2004, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[92] A. Ludolph,et al. Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model , 2004, Journal of Neurology.
[93] A. Ludolph,et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS , 2004, Neurology.
[94] R. Forbes,et al. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. , 2004, Age and ageing.
[95] A. Hays,et al. Expression of peripherin in ubiquinated inclusions of amyotrophic lateral sclerosis , 2004, Journal of the Neurological Sciences.
[96] G. Filippini,et al. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period , 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[97] E. Bertini,et al. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[98] John A Tainer,et al. ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. , 2003, Journal of molecular biology.
[99] L. Salminen,et al. Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells. , 2002, Pharmacology & toxicology.
[100] C. Dobson. Protein folding and its links with human disease. , 2002, Biochemical Society symposium.
[101] J. Joseph,et al. Bicarbonate Enhances Peroxidase Activity of Cu,Zn-Superoxide Dismutase , 2002, The Journal of Biological Chemistry.
[102] P. Worms. The epidemiology of motor neuron diseases: a review of recent studies , 2001, Journal of the Neurological Sciences.
[103] S. Sakoda,et al. Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation , 2001, Acta Neuropathologica.
[104] C. Soto,et al. Protein misfolding and disease; protein refolding and therapy , 2001, FEBS letters.
[105] M. Gurney,et al. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[106] E. Wanker. Protein aggregation in Huntington's and Parkinson's disease: implications for therapy. , 2000, Molecular medicine today.
[107] K. Fischbeck,et al. A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4 ) localizes to a 500-kb interval on chromosome 9q34 , 2000, Neurogenetics.
[108] T. Burjanadze. New analysis of the phylogenetic change of collagen thermostability. , 2000, Biopolymers.
[109] P. Andersen,et al. Genetic factors in the early diagnosis of ALS , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[110] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[111] A. Chiò. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis , 1999, Journal of Neurology.
[112] J. Cedarbaum,et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.
[113] J. Shefner,et al. Association of Cigarette Smoking with Amyotrophic Lateral Sclerosis , 1999, Neuroepidemiology.
[114] A. Ludolph,et al. Problems and pitfalls in the diagnosis of ALS , 1999, Journal of the Neurological Sciences.
[115] A Al-Chalabi,et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. , 1999, Human molecular genetics.
[116] Michael Swash,et al. Early diagnosis of ALS/MND , 1998, Journal of the Neurological Sciences.
[117] L. Bruijn,et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.
[118] S. Barnes,et al. Superoxide Dismutase Catalyzes Nitration of Tyrosines by Peroxynitrite in the Rod and Head Domains of Neurofilament‐L , 1997, Journal of neurochemistry.
[119] D. Figlewicz,et al. Aggregation of Mutant Cu/Zn Superoxide Dismutase Proteins in a Culture Model of ALS , 1997, Journal of neuropathology and experimental neurology.
[120] P. Andersen,et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. , 1996, Brain : a journal of neurology.
[121] M. Beal,et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.
[122] C. Warlow,et al. Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[123] D. Bredesen,et al. Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.
[124] D. Borchelt,et al. Motor neuron disease caused by mutations in superoxide dismutase 1. , 1995, Current opinion in neurology.
[125] S H Appel,et al. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. , 1995, Brain : a journal of neurology.
[126] Robert H. Brown,et al. Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice , 1995, Cell.
[127] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[128] M. Pericak-Vance,et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. , 1993, Science.
[129] M. Carson,et al. ALS, SOD and peroxynitrite , 1993, Nature.
[130] N. Mandahl,et al. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma , 1993, Nature.
[131] R. Larson,et al. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma , 1993, Nature Genetics.
[132] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[133] M. Beal. Mechanisms of excitotoxicity in neurologic diseases , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[134] E. Getzoff,et al. Faster superoxide dismutase mutants designed by enhancing electrostatic guidance , 1992, Nature.
[135] J. Tainer,et al. Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[136] J. Tainer,et al. Thermostabilization of recombinant human and bovine CuZn superoxide dismutases by replacement of free cysteines. , 1991, Biochemical and biophysical research communications.
[137] M. Swash,et al. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. , 1991, Brain : a journal of neurology.
[138] G. Bruyn,et al. Autosomal dominant adult amyotrophic lateral sclerosis A six generation dutch family , 1990, Journal of the Neurological Sciences.
[139] M. Hamida,et al. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. , 1990, Brain : a journal of neurology.
[140] D. B. Williams,et al. Familial motor neuron disease: Differing penetrance in large pedigrees , 1988, Journal of the Neurological Sciences.
[141] M. Swash,et al. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[142] L. Kurland,et al. Familial adult motor neuron disease: amyotrophic lateral sclerosis , 1986, Neurology.
[143] R. Palm,et al. Motor Neuron Disease and Heavy Manual Labor: An Epidemiologic Survey of Värmland County, Sweden , 1984 .
[144] Peter A. Kollman,et al. Electrostatic recognition between superoxide and copper, zinc superoxide dismutase , 1983, Nature.
[145] John A. Tainer,et al. Structure and mechanism of copper, zinc superoxide dismutase , 1983, Nature.
[146] L. Forsgren,et al. Epidemiology of motor neuron disease in northern Sweden , 1983, Acta neurologica Scandinavica.
[147] R. Fogelholm,et al. Amyotrophic lateral sclerosis in Middle‐Finland: an epidemiological study , 1983, Acta neurologica Scandinavica.
[148] J. Richardson,et al. Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase. , 1980, Journal of molecular biology.
[149] I. Fridovich,et al. Subunit association and side-chain reactivities of bovine erythrocyte superoxide dismutase in denaturing solvents. , 1979, Biochemistry.
[150] J. Brody,et al. Familial motor neuron disease , 1976, Neurology.
[151] I. Fridovich,et al. On the stability of bovine superoxide dismutase. The effects of metals. , 1973, The Journal of biological chemistry.
[152] L. Olivares,et al. Mexican "resistance" to amyotrophic lateral sclerosis. , 1972, Archives of neurology.
[153] W. Haberlandt. Genetic aspects of amyotrophic lateral sclerosis and progressive bulbar paralysis. , 1959, Acta geneticae medicae et gemellologiae.
[154] J. Folch,et al. CEREBROCUPREIN I. A COPPER‐CONTAINING PROTEIN ISOLATED FROM BRAIN , 1957, Journal of neurochemistry.
[155] D. Keilin,et al. Haemocuprein and Hepatocuprein, Copper-Protein Compounds of Blood and Liver in Mammals , 1938 .
[156] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[157] D. Annane,et al. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. , 2009, The Cochrane database of systematic reviews.
[158] W. Bradley,et al. The ALS/PDC syndrome of Guam and the cycad hypothesis. , 2009, Neurology.
[159] P. Andersen. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene , 2006, Current neurology and neuroscience reports.
[160] A. Sik,et al. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis , 2006, Nature Neuroscience.
[161] W. Burke. Neuroprotective agents for clinical trials in ALS: systematic assessment. , 2006, Neurology.
[162] R. Miller,et al. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[163] S. Hadano,et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.
[164] O. Hardiman,et al. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. , 2000, Archives of neurology.
[165] T. Lam,et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. , 1996, Neuroepidemiology.
[166] E R James,et al. Superoxide dismutase. , 1994, Parasitology today.
[167] Z A Arlin,et al. Treatment of acute promyelocytic leukemia. , 1992, Blood.
[168] K. Purohit,et al. Juvenile amyotrophic lateral sclerosis. , 1971, Indian pediatrics.
[169] Jm Charcot,et al. Deux cas d’atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere , 1869 .